# Suvoda's latest platform release creates a global experience across study data, patient engagement, scheduling, payments, and clinical trial operations

- Link: https://www.thailand-business-news.com/pr-news/suvodas-latest-platform-release-creates-a-global-experience-across-study-data-patient-engagement-scheduling-payments-and-clinical-trial-operations
- Published: 2026-09-30T21:00:00+07:00
- Author: PR Newswire

|   |

CONSHOHOCKEN, Pa., Sept. 30, 2026 /PRNewswire/ — [Suvoda](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4783534-1&h=1613527542&u=https%3A%2F%2Fwww.suvoda.com%2F&a=Suvoda),
a global clinical trial technology company, today announced a new release of important
advancements since unifying the market-leading Suvoda and Greenphire products on
one platform. Innovations in AI and new product functionality are expanding the 
platform’s capabilities, reducing manual work for users, and giving patients, sites,
and sponsors more choices in how to engage with their trial technology worldwide.

The [Suvoda Platform](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4783534-1&h=2403427472&u=https%3A%2F%2Fwww.suvoda.com%2Fproducts%2Fclinical-trial-technology-platform&a=Suvoda+Platform)
connects technology and services across the mission-critical, time-sensitive moments
in a clinical trial, so that sponsors, CROs, sites, and patients have the insight
to make smarter decisions and the ease to move faster. It solves a longstanding 
challenge in clinical trials: study teams have had to stitch together technology
that was never built to work together, with separate vendors, logins, and support
teams in order to handle randomization, drug supply, questionnaire completion, payments,
travel, and patient consent. Suvoda is turning that patchwork experience into a 
single platform the industry has not seen before.

Advancements include:

 ◦ **AI built into the platform.** Suvoda is bringing AI capabilities across its
   unified platform, beginning with RTSM and eCOA and expanding into financial services
   such as patient payments. The results are significant. Suvoda’s agentic RTSM 
   capability is demonstrating up to an 80% reduction in kickoff-to-UAT timelines.
   Sofia, Suvoda’s conversational AI assistant, lets sponsors and sites find information
   and take permissioned action across multiple languages, with every action logged
   and auditable. Humans retain sign-off authority at every step.
 ◦ **One login for eight connected products. **The new Product Launchpad, rolling
   out across global trials, lets study teams move between [RTSM/IRT](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4783534-1&h=773988925&u=https%3A%2F%2Fwww.suvoda.com%2Frtsm-irt-clinical-trial&a=RTSM%2FIRT),
   [eCOA](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4783534-1&h=4261003694&u=https%3A%2F%2Fwww.suvoda.com%2Fproducts%2Fecoa&a=eCOA),
   [eConsent](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4783534-1&h=3301020118&u=https%3A%2F%2Fwww.suvoda.com%2Fproducts%2Feconsent&a=eConsent),
   [Scheduling](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4783534-1&h=1619272098&u=https%3A%2F%2Fwww.suvoda.com%2Fscheduling-for-clinical-trials&a=Scheduling),
   [Patient Payments](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4783534-1&h=3887302231&u=https%3A%2F%2Fwww.suvoda.com%2Fproducts%2Fgreenphire-patient-payments-for-clinical-trials&a=Patient+Payments),
   [Travel](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4783534-1&h=2561803602&u=https%3A%2F%2Fwww.suvoda.com%2Fproducts%2Fgreenphire-patient-travel-product-for-clinical-trials&a=Travel),
   [Site Payments](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4783534-1&h=387777132&u=https%3A%2F%2Fwww.suvoda.com%2Fsite-payments-for-clinical-trials&a=Site+Payments),
   and [Budgeting & Benchmarking](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4783534-1&h=3954039221&u=https%3A%2F%2Fwww.suvoda.com%2Fbudgeting-benchmarking-for-clinical-trials&a=Budgeting+%26+Benchmarking)
   without switching systems. A unified data layer means participant data entered
   once in RTSM can flow automatically across products, eliminating re-entry.
 ◦ **Faster, more confident sponsor and CRO decisions.** New reporting and self-
   service enhancements give sponsors and CROs more choice and control. Examples
   include a finance and travel reporting portal that enables self-service access
   to the study data they need when they need it. The Budgeting & Benchmarking solution
   now allows negotiations to happen right in the platform rather than offline, 
   and payment data feeds back to sharpen fair-market value benchmarks in real time.
 ◦ **A better patient experience.** The [award-winning](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4783534-1&h=1476640531&u=https%3A%2F%2Fwww.globenewswire.com%2Fnews-release%2F2026%2F05%2F07%2F3290215%2F0%2Fen%2Fsuvoda-patient-app-earns-best-patient-relationship-management-solution-in-2026-medtech-breakthrough-awards-program.html&a=award-winning)
   [Suvoda App](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4783534-1&h=3289350318&u=https%3A%2F%2Fwww.suvoda.com%2Fpatient-app-for-clinical-trials&a=Suvoda+App)
   gives patients a single place to track visits, book rides, complete questionnaires,
   and receive micropayments upon task completion. Sites can conduct video calls
   for at-home patient visits and provide their schedule availability for easier
   appointment scheduling. Patients across the globe can receive reimbursement through
   the payment method that works for them such as digital wallet payments, including
   Alipay in China. For sites, this means fewer inbound calls on payment and travel
   status and fewer manual handoffs.

"This release shows what a platform-based and AI-enabled product suite makes possible.
Sites can spend less time reconciling systems, patients can have an easier clinical
trial experience wherever they are, and sponsors get faster answers to their important
questions. I’m immensely proud of our teams. They have embraced a bold vision for
the future and have brought it to life through innovative technology designed to
make clinical trial work better for everyone involved," said [Jagath Wanninayake](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4783534-1&h=49046745&u=https%3A%2F%2Fwww.linkedin.com%2Fin%2Fjwanninayake%2F&a=Jagath+Wanninayake),
CEO, Suvoda.

Suvoda is a global clinical trial technology company with a market-leading, real-
time software platform that empowers sponsors and CROs to make confident decisions
and sites and patients to take calm, controlled action. Suvoda delivers interconnected,
action-driven software solutions and industry-leading services and support, so that
even in the most time-sensitive, mission-critical moments, life-changing studies
keep moving forward. Suvoda recently merged with Greenphire, a leading provider 
of clinical trial financial management and patient support tools. To learn more,
visit [suvoda.com](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4783534-1&h=3951035459&u=https%3A%2F%2Fwww.suvoda.com%2F&a=suvoda.com)
and follow Suvoda on [LinkedIn](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4783534-1&h=2334107746&u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fsuvoda%2F&a=LinkedIn).

**Media Contact: **

Robin Abadía, Director, External Communications
[marketing@suvoda.com](https://www.thailand-business-news.com/pr-news/marketing@suvoda.com)

---

  |  This article was produced by Cision PR Newswire, our trusted news partner. The views expressed and the content presented here are solely those of the author and may not fully reflect the opinions of Thailand Business News. |

---

 
**Read the original article :** [Suvoda's latest platform release creates a global experience across study data, patient engagement, scheduling, payments, and clinical trial operations ](http://www.prnasia.com/story/archive/5057479_AE57479_0?rand=184833)
